We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.76%
4 Financials 5.47%
5 Communication Services 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMS icon
3576
Fresenius Medical Care
FMS
$13.2B
$320K ﹤0.01%
+15,345
New +$295K
FBRT
3577
Franklin BSP Realty Trust
FBRT
$601M
$319K ﹤0.01%
+23,633
New +$311K
IPG
3578
DELISTED
Interpublic Group of Companies
IPG
$319K ﹤0.01%
+9,777
New +$294K
KRON
3579
DELISTED
Kronos Bio
KRON
$319K ﹤0.01%
254,987
-115,780
-31% -$128K
NNOX icon
3580
CALL
Nano X Imaging
NNOX
$62.4M
$319K ﹤0.01%
+50,000
New +$312K
SHC icon
3581
Sotera Health
SHC
$4.95B
$318K ﹤0.01%
18,897
-66,751
-78% -$945K
EG icon
3582
CALL
Everest Group
EG
$15.2B
$318K ﹤0.01%
900
MLR icon
3583
Miller Industries
MLR
$586M
$318K ﹤0.01%
+7,523
New +$296K
ALX
3584
Alexander's
ALX
$1.4B
$318K ﹤0.01%
1,489
+363
+32% +$68.7K
QCRH icon
3585
QCR Holdings
QCRH
$1.65B
$317K ﹤0.01%
5,431
-5,266
-49% -$273K
CATO icon
3586
Cato Corp
CATO
$65.9M
$317K ﹤0.01%
44,338
-10,775
-20% -$76.3K
JBSS icon
3587
John B. Sanfilippo & Son
JBSS
$949M
$315K ﹤0.01%
3,060
PKW icon
3588
Invesco BuyBack Achievers ETF
PKW
$1.69B
$315K ﹤0.01%
+3,184
New +$291K
BTG icon
3589
B2Gold
BTG
$5.16B
$315K ﹤0.01%
99,764
-211,795
-68% -$668K
PNFP icon
3590
Pinnacle Financial Partners Inc
PNFP
$15.5B
$315K ﹤0.01%
3,614
-55,405
-94% -$4.01M
CSV icon
3591
Carriage Services
CSV
$618M
$314K ﹤0.01%
12,556
-929
-7% -$21.9K
BGFV
3592
DELISTED
Big 5 Sporting Goods
BGFV
$310K ﹤0.01%
+48,966
New +$315K
TNYA icon
3593
Tenaya Therapeutics
TNYA
$168M
$310K ﹤0.01%
95,567
-29,073
-23% -$62.8K
MVIS icon
3594
Microvision
MVIS
$88.2M
$310K ﹤0.01%
+116,401
New +$267K
SWAV
3595
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$308K ﹤0.01%
1,617
-2,883
-64% -$545K
RGR icon
3596
Sturm, Ruger & Co
RGR
$610M
$304K ﹤0.01%
+6,692
New +$321K
SHAK icon
3597
Shake Shack
SHAK
$2.3B
$304K ﹤0.01%
4,100
-367,816
-99% -$22.6M
BNED icon
3598
Barnes & Noble Education
BNED
$412M
$303K ﹤0.01%
2,034
+268
+15% +$29.8K
UVSP icon
3599
Univest Financial
UVSP
$1.23B
$302K ﹤0.01%
13,690
-39,923
-74% -$748K
SAFE
3600
Safehold
SAFE
$1.19B
$302K ﹤0.01%
12,887
-85,629
-87% -$1.61M

Similar funds

D.E. Shaw & Co's Q4 2023 Portfolio in Review

As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
  • D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
  • D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.